History of colorectal cancer (CRC) in a first degree relative increases the risk of this disease by twofold to threefold.' As most CRCs arise in pre-existing adenomas,2 one would expect either that the prevalence of adenomas would be higher among subjects with a positive family history, or that a larger proportion of their adenomas would undergo malignant transformation.
The extent to which genetic susceptibility plays a part in the 90% or so of new cases of CRC not associated with familial adenomatous polyposis (FAP) or hereditary non-polyposis colorectal cancer (HNPCC)3 is unknown. If inherited genetic factors are present, it is possible that they may affect varying stages of the adenoma-carcinoma sequence. Thus, in some families, while the prevalence of colorectal adenomas may not be increased, adenomas may progress to CRC more frequently than usual (similar to the situation in HNPCC4). We sought to discover if a family history of CRC not due to FAP or HNPCC is associated with an increased prevalence of adenomas in general, or with an increased proportion of the large, dysplastic adenomas most likely to undergo malignant change.5
Methods
Study subjects Cases and controls were identified on the basis of findings at colonoscopy, and were drawn retrospectively from all patients who underwent colonoscopy at the Royal Brisbane Hospital during 1980-1982 and 1985 , were alive and aged below 75 years at time of study, and had a known current address.
(Colonoscopy patients in 1983-1984 were excluded as they were involved in another project.) History of gastrointestinal disease and cancer, indications for colonoscopy, and colonoscopy findings were recorded from hospital charts, physicians' records, and colonoscopy reports, and patients younger than 20 years at colonoscopy, or with a history of colorectal resection, CRC, FAP, or inflammatory bowel disease were excluded. To avoid possible selection bias, 27 patients (six with polyps) whose sole indication for colonoscopy was a positive family history of CRC were also excluded.
For remaining patients, copies of histopathology reports were sought for all polyps removed at colonoscopy. Cases were defined as patients with histologically confirmed adenomatous polyps diagnosed at the study colonoscopy, and a few eligible patients who had had adenomatous polyps removed within two years prior to the study period and who returned for a follow up colonoscopy during the study years. Controls were defined as patients with no polyps at study colonoscopy, nor with any history of colorectal polyps.
Data collection A questionnaire mailed to the cases and controls asked about their history of bowel conditions and symptoms, reasons for initial presentation to their doctor prior to colonoscopy, and family medical history. The family history questions asked for names of all first degree relatives (parents, siblings, and children), their current ages or ages at death, whether any of these, or other, relatives had had cancer or polyps of the bowel, bowel obstruction, other bowel diseases or cancer at other sites, and if so, the ages when these conditions occurred.
Histological classification ofpolyps
All histological examinations during the study years were performed at the Royal Brisbane Hospital or in one of two To examine the relation between family history and malignant potential of adenomas, we compared the prevalence of positive family history among cases with large, dysplastic, or villous adenomas with that among controls (Table II) . When each criterion was examined separately, the presence of a positive family history was most strongly linked to moderate or severe dysplasia (positive family history in any first degree relatives was present in three of 17 (17-6%) such cases compared with 93 of 882 (105%) controls (OR= 1.8, 95% CI 04, 5.7)). A similar pattern was seen for the small group of cases whose adenomas showed all three indicators of malignant potential (OR= 1-7, 95% CI=0-4, 5.3). In the presence of two or more positive relatives, these ORs were 14.1 (95% CI=2.0, 62.9) and 13.2 (95% CI= 1.9, 58.2), respectively. Although it seems all the effect may lie with the strong family history, cases are too few to truly distinguish real differences. Neither size nor villous pattern modified the general family history association.
Discussion
The hypothesis that a history of CRC in any first degree relatives confers an increased risk of adenomas in general was not supported by these data. This parallels another Australian study,'0 but is at odds with other case-control studies,l [11] [12] [13] which have found twofold to fivefold increased risks for adenomas associated with any positive family history of CRC. Two of them'2 13 almost certainly overestimated the relation, as colonoscopy patients were compared with asymptomatic (nongastrointestinal) patients. Such a contrast is likely to be biased as family history itself is a reason for referral for colonoscopy. In the other two studies, self reported family history was not verified, little was said about reasons for referral, it is not clear that HNPCC families were excluded, and patients with different strengths of family history were combined in the analyses. Thus the true overall relation remains unclear.
In the one controlled, prospective colonoscopy study of which we are aware, the prevalence of adenomas among patients with a family history was 14%, and in the rest 8%, a difference statistically non-significant. 14 Among patients with two positive first degree relatives, adenomas were almost twice as prevalent (24%) as among those with only one (13%). Consistent with this, and with reports of colonoscopy screening of patients with a positive family history,15 16 our results also suggest that patients with two or more first degree relatives with CRC may be at increased risk for colorectal adenomas, and possibly at greatly increased risk for adenomas with moderate to severe dysplasia. This supports the notion that some families, in addition to those with FAP, have an inherited susceptibility to develop colorectal adenomas,17 and that such adenomas may have a heightened potential to progress to carcinoma. 5 All patients in this study, both cases and controls, sought medical attention and were referred for colonoscopy because of bowel symptoms. Although it is clear that family history itself plays some part in a patient's decision to present to their doctor when they develop bowel symptoms, this should apply equally to cases and controls, and is therefore unlikely to cause a bias in this study. In fact, negative colonoscopy controls, as used here, are in theory an ideal comparison group for the cases. In support of this, a similar proportion of cases and controls stated that a concern about family history was one of the reasons for their presentation to their doctor, and, further, results were unchanged after adjusting in the analysis for whether or not family history (in addition to bowel symptoms) was one of the reasons for the patient's presentation or referral.
The history.'9 Our results support this, and suggest that colonoscopy screening among people with one first degree relative with CRC would yield no more adenomas than would be found in others of the same age and sex. Our findings do imply that people with two or more first degree relatives with CRC may be at greater risk for colorectal adenomas, and therefore might gain most from colonoscopy screening, particularly if they also have a relative excess of more dysplastic lesions. Clearly, these possibilities require further exploration and testing among larger populations.
